Abrysvo
Product Images NDC 0069-0344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Abrysvo (NDC 0069-0344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (Abrysvo 01)

Vial (Abrysvo 01)
Abrysvo, a vial for injection, is shown with a gray rubber stopper and a silver metal seal around the neck. The vial contains a clear liquid visible through the transparent glass container. No additional labeling or text is visible.*
FDA Label Image

Syringe (Abrysvo 02)

Syringe (Abrysvo 02)
An illustration diagram of a syringe labeled with its parts: the 'Syringe cap' covering the needle end and the 'Luer lock adapter' near the plunger section. The syringe is shown in a side view with a plunger at one end and a cap at the other.*
FDA Label Image

Vial Adapter (Abrysvo 03)

Vial Adapter (Abrysvo 03)
The image shows a vial labeled Abrysvo. The vial includes measurement markings and a cap on top. The product is associated with Pfizer Laboratories Div Pfizer Inc and is available in strengths including 0.06 mg per 0.5 mL, as indicated by the product data.*
FDA Label Image

Step 1 (Abrysvo 04)

Step 1 (Abrysvo 04)
An instructional illustration showing hands removing a cap or lid from a small medical vial or container. The image likely demonstrates how to prepare or access a medication, such as Abrysvo, prior to administration.*
FDA Label Image

Step 2 (Abrysvo 05)

Step 2 (Abrysvo 05)
An instructional illustration showing a hand securing a cap onto a small vial, demonstrating the step to close or seal the vial. This visual appears related to the preparation or use of the Abrysvo vaccine product.*
FDA Label Image

Step 3 (Abrysvo 06)

Step 3 (Abrysvo 06)
An instructional illustration showing a person twisting or removing a cap from a bottle or vial with one hand while stabilizing the container with the other hand. The image likely demonstrates how to open the product packaging or prepare the dosage form for administration.*
FDA Label Image

Step 4 (Abrysvo 07)

Step 4 (Abrysvo 07)
An instructional illustration showing a person using a syringe to withdraw medication from a vial. The image emphasizes proper technique for drawing fluid from the vial into the syringe.*
FDA Label Image

Step 5 (Abrysvo 08)

Step 5 (Abrysvo 08)
An instructional illustration showing a hand pressing down on the plunger of a prefilled syringe to administer the dose into a vial or container below. The image focuses on the mechanical action of dose delivery commonly associated with prefilled injectable medications like Abrysvo.*
FDA Label Image

Step 6 (Abrysvo 09)

Step 6 (Abrysvo 09)
An instructional illustration showing a hand holding a prefilled syringe with a needle cover. The syringe is positioned above a vial, indicating preparation for injection or medication withdrawal. The image demonstrates proper handling and alignment technique for injection preparation.*
FDA Label Image

Step 7 (Abrysvo 10)

Step 7 (Abrysvo 10)
An instructional illustration showing a hand holding a vaccine vial and another hand using a syringe to withdraw the vaccine from the vial. The drawing focuses on the technique for vaccine preparation and injection.*
FDA Label Image

Step 8 (Abrysvo 11)

Step 8 (Abrysvo 11)
An instructional illustration showing the attachment of a needle to a syringe. The image depicts a hand aligning the needle hub with the syringe tip and guiding the needle to be securely connected, indicated by directional arrows.*
FDA Label Image

Step 9 (Abrysvo 12)

Step 9 (Abrysvo 12)
An instructional illustration showing a close-up of a syringe and vial, demonstrating the process of drawing medication into the syringe using a needle. The image highlights proper technique for filling the syringe from the vial.*
FDA Label Image

Logo (Abrysvo 13)

FDA Label Image

Principal Display Panel (10 Vial/Syringe Kit Carton)

Principal Display Panel (10 Vial/Syringe Kit Carton)
Packaging label for Abrysvo Respiratory Syncytial Virus Vaccine by Pfizer Laboratories Div Pfizer Inc. The label details a kit for intramuscular use containing 10 vials of lyophilized antigen component, 10 syringes of sterile water diluent, and 10 vial adapters. Each dose after reconstitution is approximately 0.5 mL. The label emphasizes the combination of components before use and includes usage and manufacturing information.*
FDA Label Image

Principal Display Panel (5 Vial/Syringe Kit Carton)

Principal Display Panel (5 Vial/Syringe Kit Carton)
Packaging label for Abrysvo Respiratory Syncytial Virus Vaccine by Pfizer Laboratories Div Pfizer Inc. The label indicates it is for intramuscular use only, with each single dose approximately 0.5 mL after reconstitution. The label features multicolor design bands and includes storage instructions, lot and expiration placeholders, and a barcode. The package is identified with NDC 0069-0344-05.*
FDA Label Image

Principal Display Panel (1 Vial/Syringe Kit Carton)

Principal Display Panel (1 Vial/Syringe Kit Carton)
Packaging label for Abrysvo Respiratory Syncytial Virus Vaccine by Pfizer Laboratories Div Pfizer Inc. The label indicates a kit containing 1 vial with lyophilized antigen component, 1 syringe with sterile water diluent, and 1 vial adapter for intramuscular use. The single dose after reconstitution is approximately 0.5 mL.*
FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
Label for Abrysvo lyophilized antigen component, vial containing approximately 0.5 mL after reconstitution. The label states this component is not to be used alone and must be reconstituted with sterile water diluent to form the Respiratory Syncytial Virus Vaccine (Abrysvo). It includes NDC 0069-0207-01 and is labeled Rx only by Pfizer Inc.*
FDA Label Image

Principal Display Panel (1 Syringe Label)

Principal Display Panel (1 Syringe Label)
Label for Sterile Water Diluent Component used with Abrysvo Respiratory Syncytial Virus Vaccine by Pfizer Inc. It includes instructions not to use alone and to add to lyophilized antigen component. Displays NDC 0069-0250-01, U.S. license number 2001, and indicates Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.